Investors & Media

Investor FAQs

Where is Entasis Therapeutics Holdings Inc. corporate headquarters?

Our corporate headquarters are located at Gatehouse Park BioHub, 35 Gatehouse Drive, Waltham, Massachusetts 02451.

When was Entasis Therapeutics Holdings Inc. founded?

The Company was founded in 2015.

When and Where was Entasis Therapeutics Holdings Inc. incorporated?

Entasis Therapeutics Holdings Inc. was incorporated in Delaware on March 23, 2018.

When did Entasis Therapeutics Holdings Inc. go public? What was the price?

Entasis Therapeutics Holdings Inc. completed its initial public offering on September 25, 2018 at a price of $15.00.

What is Entasis Therapeutics Holdings Inc. fiscal year?

The Company’s fiscal year ends December 31st of each year.

How is Entasis Therapeutics Holdings Inc. stock traded?

Our common stock is listed on the Nasdaq Global Market under the symbol “ETTX.”

Who is Entasis Therapeutics Holdings Inc. transfer agent?

The transfer agent and registrar for the common stock of Entasis Therapeutics Holdings  Inc. stock is:
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 962-4284

Whom do I contact with questions about my stock?

For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A., 250 Royall Street, Canton, Massachusetts 02021. Each stockholder in question must sign a request for an address change.

Phone: (800) 962-4284
Website: www-us.computershare.com/

To transfer stock or replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A.

How can I buy or sell Entasis Therapeutics Holdings Inc.’s common stock?

You may purchase shares of our common stock through any brokerage, bank or other financial institution that is authorized to trade in shares of publicly held securities.

Does Entasis Therapeutics Holdings Inc. pay dividends?

We have never declared or paid any cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business and do not intend to declare or pay any cash dividends in the foreseeable future.

Does Entasis Therapeutics Holdings Inc. have a dividend reinvestment plan?

No, because we do not currently pay dividends, we do not offer a dividend reinvestment plan.

Does Entasis Therapeutics Holdings Inc. have a direct stock purchase program?

No, we do not sell stock directly to the public.

What is Entasis Therapeutics Holdings Inc.’s CUSIP number?

Our CUSIP number is 293614 103.

When does Entasis Therapeutics Holdings Inc. release earnings information?

Our fiscal year ends on December 31 of each year, with quarters ending on March 31, June 30, and September 30. Information regarding the timing of our earnings releases may be in the Investors – Press Releases and Investors – Events & Presentations pages of our website.

Who is Entasis Therapeutics Holdings Inc.’s auditor?

The auditor for Entasis Therapeutics Holdings Inc. is KPMG LLP located in Cambridge, Massachusetts.

Who is Entasis Therapeutics Holdings Inc.’s legal counsel?

Legal counsel for Entasis Therapeutics Holdings Inc. is Cooley LLP, located in Washington, D.C.

Where can I find out more about Entasis Therapeutics Holdings Inc.?

To find out more about Entasis Therapeutics Holdings Inc. visit our webpage at http://entasistx.com.

Where can I get the latest corporate news releases and financial reports?

Entasis Therapeutics Holdings Inc.'s press releases and financial reports can be viewed under the “News & Events” and "SEC Filings" sections of the Investors & Media page located at our website http://entasistx.com.

How can I view documents Entasis Therapeutics Holdings Inc. has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Entasis Therapeutics Holdings Inc. SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the Investors & Media page located at our website http://entasistx.com.

Who makes up the Entasis Therapeutics Holdings Inc. Executive Management team and Board of Directors?

For a list of the Executive Management team and Board of Directors please visit the “Corporate Governance” section of the "Investors & Media" page on our website http://entasistx.com.

Whom should I contact regarding investor inquiries?

For investor inquiries please contact:

Kyle Dow
Entasis Therapeutics Holdings Inc.
Director, Business Development
EMAIL: IR@entasistx.com
PHONE: +1 781 810 0114

Christopher F. Brinzey
Westwicke Partners
EMAIL: chris.brinzey@westwicke.com
PHONE: + 1 339-970-2843